Page last updated: 2024-12-06

2-oxindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2-oxindole: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

indolin-2-one : An indolinone carrying an oxo group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID321710
CHEMBL ID40823
CHEBI ID31697
SCHEMBL ID19504
SCHEMBL ID9305641
SCHEMBL ID4787148
SCHEMBL ID4787144
SCHEMBL ID4096312
MeSH IDM0079693

Synonyms (85)

Synonym
EN300-20422
BB 0257524
1,3-dihydro-indol-2-one
2h-indol-2-one, 1,3-dihydro-
brn 0114692
2-oxindoline
2,3-dihydroindol-2-one
einecs 200-429-5
nsc 274863
inchi=1/c8h7no/c10-8-5-6-3-1-2-4-7(6)9-8/h1-4h,5h2,(h,9,10
AH-034/32845032
CHEBI:31697 ,
1,3-dihydro-2h-indol-2-one
diclofenac impurity e
indol-2-ol
indoline-2-one
indolin-2-one
oxindole
2-oxoindoline
59-48-3
nsc274863
nsc-274863
2-indolinone
oxindol
2-oxindole
indol-2(3h)-one
1,3-dihydroindol-2-one
2-oxindole, 97%
STK336410
indolin-2(1h)-one
2-oxoindole
CHEMBL40823
HMS1647D16
2-ketoindoline
O0272
AKOS000119409
A24270
2,3-dihydro-1h-indol-2-one
0s9338u62h ,
unii-0s9338u62h
5-21-08-00007 (beilstein handbook reference)
BP-12514
FT-0631265
AB00523
bdbm50434120
diclofenac sodium impurity e [ep impurity]
diclofenac potassium impurity i [ep impurity]
diclofenac potassium impurity e [ep impurity]
S4861
1,3-dihydro-indol-2-one-d4
CX1001
AM807053
SCHEMBL19504
CG-0513
mfcd00005711
SY004718
SCHEMBL9305641
CS-M2997
indolin 2-one
2(1h,3h)-indolone
indolinone
1,3-dihydro-2h-indol-2-on
2oxindole
2(1h,3h)indolone
SCHEMBL4787148
SCHEMBL4787144
SCHEMBL4096312
2,3-dihydroindole-2-one
o-(aminophenyl)-acetic acid lactam
1,3-dihydro-2h-indol-2-one #
J-400304
STR01316
HY-Y0061
F0918-7910
AC-3269
2-oxindole, purum, >=97.0% (hplc)
1,3-dihydro-(2h)-indol-2-one
2-oxindole pound>>diclofenac impurity e
BCP21784
DTXSID80870389
Q2018788
CCG-266121
AB7349
oxindole (2-indolone)
Z104478112

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Masking the proline N,N-dimethyl amide moiety as an oxazole and attaching a benzylic amine moiety to the northern phenyl ring resulted in potent and selective V1b receptor antagonists with improved metabolic stability and improved pharmacokinetic properties in rat."( Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties.
Backfisch, G; Bhowmik, S; Geneste, H; Hornberger, W; Lubisch, W; Netz, A; Oost, T; Unger, L; van Gaalen, MM; Wernet, W, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" The closely related compound 27 demonstrated good oral bioavailability in dog and rhesus."( The discovery of highly potent CGRP receptor antagonists.
Bednar, RA; Bell, IM; Blair Zartman, C; Bruno, JG; Fay, JF; Gallicchio, SN; Graham, SL; Johnston, VK; Kane, SA; Moore, EL; Mosser, SD; Quigley, AG; Salvatore, CA; Stump, CA; Theberge, CR; Vacca, JP; Williams, TM; Zhang, XF, 2009
)
0.35
" Triazole derivative 13 was found to have moderate bioavailability in the rat and demonstrated potent in-vivo activity in an acute model of inflammation."( Indolin-2-one p38α inhibitors III: bioisosteric amide replacement.
Aguilar, N; Aiguadé, J; Balagué, C; Caturla, F; Domínguez, M; Eastwood, P; Gómez, E; González, J; Matassa, V; Mir, M; Orellana, A, 2011
)
0.37
" Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model."( Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Chen, H; Shi, PY; Wold, EA; Ye, N; Zhou, J, 2016
)
0.43
" Chemical modification of the melatonin structure can in-crease efficiency, bioavailability and selectivity of these analogs."( [Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma].
Beznos, OV; Chesnokova, NB; Grigoryev, AV; Lozinskaya, NA; Volkova, MS; Zaryanova, EV; Zefirov, NA, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
"The present study was designed to select the effective dosage range of Z24 [3Z-3-[(1H-pyrrol-2-yl)-methylidene]-1-(1-piperidinylmethyl)-1,3-2H-indol-2-one], a novel synthetic indolin-2-ketone small-molecule compound, against tumorigenesis and angiogenesis in vitro and in vivo and to investigate the primary action mechanism of Z24 on the angiogenesis by comparing with SU5416 [3-[(2,4-dimethylpyrrol-5-yl)methyllidenyl]-indolin-2-one] in the selective effects on vascular endothelial growth factor (VEGF)/basic fibroblast growth factor (bFGF) signaling and Bcl-2-related cell vitality because Z24 is a potential inhibitor of the Bcl-2 that inhibits growth of multiple tumor types in vivo in our previous study."( Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Du, GJ; Li, JJ; Li, S; Liu, HY; Wang, LL; Zheng, ZB, 2004
)
0.32
" To further explore the potential of the compound, we established an UPLC-MS/MS assay for dosage in rat plasma."( Development and full validation of an UPLC-MS/MS method for the determination of an anti-allergic indolinone derivative in rat plasma, and application to a preliminary pharmacokinetic study.
Butterweck, V; Hamburger, M; Oufir, M; Sampath, C, 2012
)
0.38
" In mice dosed with SAP there was negligible hematotoxicity, while cardiac function measurements showed a reduction in the percentage left ventricular fractional shortening compared to vehicle treated animals."( Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.
Agalou, A; Argyros, O; Asvos, X; Beis, D; Davos, CH; Fokas, D; Karampelas, T; Papakyriakou, A; Tamvakopoulos, C; Varela, A, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
indolinone
gamma-lactamA lactam in which the amide bond is contained within a five-membered ring, which includes the amide nitrogen and the carbonyl carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Cytochrome P450 - arranged by substrate type30110
Miscellaneous substrates315
DIBOA-glucoside biosynthesis713
superpathway of benzoxazinoid glucosides biosynthesis920
superpathway of benzoxazinoid glucosides biosynthesis1020
DIBOA-glucoside biosynthesis813

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ChymaseHomo sapiens (human)IC50 (µMol)1,000.00000.02602.639710.0000AID748040
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)IC50 (µMol)958.00000.06503.12999.5000AID1765893
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)IC50 (µMol)2,000.00000.02103.58609.5000AID1765894
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (31)

Processvia Protein(s)Taxonomy
angiotensin maturationChymaseHomo sapiens (human)
peptide metabolic processChymaseHomo sapiens (human)
extracellular matrix disassemblyChymaseHomo sapiens (human)
protein catabolic processChymaseHomo sapiens (human)
midbrain developmentChymaseHomo sapiens (human)
basement membrane disassemblyChymaseHomo sapiens (human)
positive regulation of angiogenesisChymaseHomo sapiens (human)
regulation of inflammatory responseChymaseHomo sapiens (human)
cellular response to glucose stimulusChymaseHomo sapiens (human)
cytokine precursor processingChymaseHomo sapiens (human)
glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of gluconeogenesis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of pH[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
insulin receptor signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of cellular ketone metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cellular response to nutrient[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cellular response to reactive oxygen species[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
glucose homeostasis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of calcium-mediated signaling[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of pH[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
insulin receptor signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
cellular response to starvation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of cellular ketone metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of fatty acid biosynthetic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
glucose homeostasis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
response to starvation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of bone resorption[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of fatty acid oxidation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
cellular response to fatty acid[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
reactive oxygen species metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
negative regulation of anoikis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
endopeptidase activityChymaseHomo sapiens (human)
serine-type endopeptidase activityChymaseHomo sapiens (human)
serine-type peptidase activityChymaseHomo sapiens (human)
peptide bindingChymaseHomo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein homodimerization activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular regionChymaseHomo sapiens (human)
cytosolChymaseHomo sapiens (human)
secretory granuleChymaseHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleChymaseHomo sapiens (human)
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular spaceChymaseHomo sapiens (human)
intracellular membrane-bounded organelleChymaseHomo sapiens (human)
cytoplasmChymaseHomo sapiens (human)
nucleoplasm[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cytosol[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase complex[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1062078Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 promastigotes after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1765894Inhibition of human PDHK4 assessed as reduction in acetyl-coenzymeA formation by RapidFire mass spectrometry2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.
AID748040Inhibition of recombinant human chymase using bis(succinoyl-L-alanyl-L-prolyl-L-phenylalanylamide) as substrate after 1 hr by fluorescence assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of potent, selective chymase inhibitors via fragment linking strategies.
AID1062080Antileishmanial activity against Leishmania infantum zymodeme MON-1 promastigotes assessed as parasite survival after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1062085Antileishmanial activity against Leishmania infantum zymodeme MON-1 promastigotes assessed as parasite survival after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1092124Inhibition of immune responses in Spodoptera exigua fifth-instar larvae assessed as inhibition of hemocytic nodulation in response to Escherichia coli challenge by stereomicroscopy2012Applied and environmental microbiology, Jun, Volume: 78, Issue:11
Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID1062082Antileishmanial activity against Leishmania infantum zymodeme MON-1 axenic amastigotes assessed as parasite survival after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1765895Inhibition of human PDHK4 assessed as reduction in acetyl-coenzymeA formation at IC50 by RapidFire mass spectrometry relative to control2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.
AID1062081Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 axenic amastigotes2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1092122Potentiation of 1000 ppm Bacillus thuringiensis-induced pathogenicity against Plutella xylostella (diamondback moth) fourth-instar larvae at 10000 ppm measured 48 hr post compound treatment2012Applied and environmental microbiology, Jun, Volume: 78, Issue:11
Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID28957Partition coefficient (logP)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID1062076Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 axenic amastigotes after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1062077Antileishmanial activity against Leishmania infantum zymodeme MON-1 axenic amastigotes assessed as parasite survival after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1062083Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 promastigotes after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1092125Inhibition of phenoloxidase activity in hemolymph of Spodoptera exigua fifth-instar larvae using DOPA substrate2012Applied and environmental microbiology, Jun, Volume: 78, Issue:11
Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID1092123Insecticidal activity against Plutella xylostella (diamondback moth) fourth-instar larvae fed on cabbage leaves soaked in compound solutions measured 48 hr post compound treatment by leaf-dipping method2012Applied and environmental microbiology, Jun, Volume: 78, Issue:11
Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID28956Partition coefficient (logP) (dodecane)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID1062084Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1062079Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1092126Inhibition of PLA2 in hemocytes of Spodoptera exigua fifth-instar larvae using pyrene-labeled phospholipid substrate by spectrofluorometry2012Applied and environmental microbiology, Jun, Volume: 78, Issue:11
Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID1765893Inhibition of human PDHK2 assessed as reduction in acetyl-coenzymeA formation by RapidFire mass spectrometry2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (719)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (0.97)18.7374
1990's6 (0.83)18.2507
2000's100 (13.91)29.6817
2010's543 (75.52)24.3611
2020's63 (8.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews19 (2.61%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other708 (97.39%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]